[Assessment of the efficacy of combined treatment of stage III throat cancer].
It was shown that a preoperative course of radiotherapy in a total focal dose of 40 Gy could be easily tolerated by cancer patients without contributing to postoperative complications development. Survival in patients with stage IIIa tumors given a course of radiotherapy preoperatively was 23.81% higher than in those operated on for tumor at the initial stage. Survival in preoperatively irradiated patients with stage IIIb tumors was higher by 17.14%.